Insights from 2023 ASH Annual Meeting
K

ASH 2023 Insights: "Pyruvate Kinase Activators - Targeting Red Cell Metabolism in Thalassemia"

By Insights from 2023 ASH Annual Meeting FEATURING Kevin Kuo
By Insights from 2023 ASH Annual Meeting FEATURING Kevin Kuo
79 views
December 17, 2023
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
21:05
Louisville Hematology Highlights

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Feat. R. Gale
28:55
The Blood Project

The ABCs of the CBC - Overview and Practical Insights on RBC Paramet…

Feat. W. Aird
28:52
James Douketis

Challenges in Antithrombotic Management: Top 3 Challenges in 2023 fo…

59:15
Medical College of Georgia - Augusta University

Hematologic Emergencies - Bleeding to Clotting

Feat. G. Raval
16:47
The Blood Project

Exercises in CBC Interpretation - Focus on WBCs and Platelets

Feat. W. Aird
34:31
Marc Zumberg

Clots in the Visceral and Cerebral Veins: Evidence, Guidelines and T…

01:54
The Blood Project

Exercises in CBC Interpretation: Non-Anemic Iron Deficiency

Feat. N. Bavli
28:25
Indy Hematology Review

Managing the Benign Hematology Consult: Treatment Recommendations fo…

Feat. C. Kessler
17:08
The Blood Project

Exercises in CBC Interpretation: Focus on Hb and Hct

Feat. W. Aird
30:23
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2023

Hereditary Hemorrhagic Telangiectasia: 2023 Update

Feat. R. Kasthuri
09:37
XIV Eurasian Hematology-Oncology Congress - EHOC 2023

State-of-the-Art in ITP: Updates and Remaining Challenges

Feat. D. Provan
18:10
Platelet Disorder Support Association (PDSA)

Establishing a Diagnosis of ITP

Feat. H. Liebman
28:20
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Inflamed - HLH, MAS, or Something Else?&quo…

Feat. A. Kumar
30:36
The Blood Project

Exercises in CBC Interpretation - Focus on RBCs

Feat. W. Aird
36:44
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2023

Approach to Bleeding of Unknown Cause

Feat. M. Lim
07:15
Weill Cornell Medicine Oncology & Hematology

Eltrombopag in ITP: Learnings From the RAISE and EXTEND Trials

Feat. J. Bussel
42:10
Insights from 2023 ASH Annual Meeting

Highlights in Red Cell and Platelet Disorders From ASH 2023

Feat. M. Blinder
28:10
Indy Hematology Review

Current Review of Benign Hematology and Coagulopathy

Feat. C. Kessler
27:07
Insights from 2023 ASH Annual Meeting

Highlights From ASH 2023 in Bone Marrow Failure Disorders: Aplastic …

Feat. P. Scheinberg
Platelet Disorder Support Association (PDSA)

Current Management of Refractory ITP

Feat. D. Kuter